Changjiang Pharmaceutical Group Stock Forum

The company's low P/S ratio may indicate anticipated poor revenue performance. Investors seem to expect limited growth rates to persist, hence the reduced stock price. If these trends persist, a share price reversal seems unlikely.

The company's recent financial struggles and slower growth may account for its lower P/S ratio. Investors, expecting limited growth rates to persist, are only willing to pay less for the stock. If medium-term revenue trends continue, a share price reversal seems unlikely.